In this research, TSG-6 and IL-1β were abnormally up-regulated in tissues from CDD patients, and over-expression of TSG-6 in HNPCs could significantly ameliorate IL-1β-induced inflammatory response, synthesis and degradation of ECM, and expression of pain-related molecules. This evidence concerns the gene TNFAIP6 and craniodiaphyseal dysplasia.